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Abstract
Reperfusion therapy must be applied as soon as pos-
sible to attenuate the ischemic insult of acute myocar-
dial infarction (AMI)�� However reperfusion is responsible 
for additional myocardial damage, which likely involves 
opening of the mitochondrial permeability transition 
pore (mPTP)�� In reperfusion injury, mitochondrial dam-
age is a determining factor in causing loss of cardio-
myocyte function and viability�� Major mechanisms of mi-
tochondrial dysfunction include the long lasting opening 
of mPTPs and the oxidative stress resulting from forma-
tion of reactive oxygen species (ROS)�� Several signal-
ing cardioprotective pathways are activated by stimuli 
such as preconditioning and postconditioning, obtained 
with brief intermittent ischemia or with pharmacologi-
cal agents�� These pathways converge on a common 
target, the mitochondria, to preserve their function af-
ter ischemia/reperfusion�� The present review discusses 
the role of mitochondria in cardioprotection, especially 
the involvement of adenosine triphosphate-dependent 
potassium channels, ROS signaling, and the mPTP�� Isch-
emic postconditioning has emerged as a new way to 
target the mitochondria, and to drastically reduce lethal 
reperfusion injury�� Several clinical studies using isch-
emic postconditioning during angioplasty now support 
its protective effects, and an interesting alternative is 
pharmacological postconditioning�� In fact ischemic post-
conditioning and the mPTP desensitizer, cyclosporine A, 
have been shown to induce comparable protection in 
AMI patients��
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INTRODUCTION
Acute myocardial infarction (AMI) is responsible for the 
death of  millions of  persons worldwide each year, with 
a mortality rate of  about 10%, and is the leading cause 
of  chronic heart failure[1]. Notwithstanding, marked im-
provements in the strategy to reduce infarct size and to 
reduce all manifestations of  postischemic injury, with 
subsequent improvement in prognosis, have been devel-
oped in recent years. Although early reperfusion is the 
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only way to salvage an ischemic organ, during the crucial 
early moments of  reperfusion, significant reversible and 
irreversible organ damage is initiated, and is referred 
to as reperfusion injury. Reperfusion injury include ar-
rhythmias, transient mechanical dysfunction of  the heart 
or “myocardial stunning”, microvascular injury and ‘‘no-
reflow’’, as well as inflammatory responses. In reperfu-
sion, cell death can occur due to apoptosis, necrosis, and 
autophagy[2-8]. Given that recent data indicate that the 
different forms of  cell death are probably interrelated[6,7], 
a better strategy to develop cardioprotective agents is not 
to define the mode of  cell death and its proportion oc-
curring during ischemia/reperfusion, but to identify me-
diators active in all forms of  cell death. In this context, 
the variation in mitochondrial membrane permeability 
appears to be one of  the major regulators of  all forms of  
cell death.
REPERFUSION INJURY: CENTRAL ROLE 
OF MITOCHONDRIA
During normal perfusion mitochondria generate adenos-
ine triphosphate (ATP), consume large amounts of  O2 
and contribute to a balanced generation and scavenging 
of  reactive oxygen species (ROS). Mitochondria are also 
involved in cellular ion homeostasis, including calcium 
homeostasis.
During ischemia, the lack of  of  O2 inhibits electron 
flow, and myocardial ATP utilization becomes inefficient. 
The proton-translocating F0F1ATP synthase, which nor-
mally produces ATP, switches into reverse mode, i.e. be-
comes an F0F1ATPase, and consumes ATP to pump pro-
tons from the matrix into the intermembrane space[9,10]. In 
prolonged ischemia, Na+/K+ ATPase is inhibited (because 
of  the drop in ATP levels) and the intracellular acidifica-
tion (induced by lactate production and the hydrolysis of  
ATP) activates the Na+/H+ exchanger (NHE), i.e. the cell 
tries to restore the intracellular pH; the resulting increase 
in intracellular Na+ concentration activates the Na+/Ca2+ 
exchanger (NCE), which lead to Ca2+ overload. Elevated 
cytosolic Ca2+ concentrations may contribute to cellular 
damage by activation of  degrading enzymes such as nu-
cleases, phospholipases and proteases culminating in the 
destruction of  the membrane integrity and leading to cell 
death if  the ischemic period is of  sufficient duration[11,12].
At reperfusion, intracellular and mitochondrial events 
such as Ca2+ overload, inadequate resynthesis of  ATP, 
loss of  membrane phospholipids, low production of  
nitric oxide (NO•) and oxidative stress by ROS contrib-
ute to reperfusion injury[13-16]. Yet, when an increase in 
ATP concentration occurs, it paradoxically contributes to 
reperfusion injury, leading to hyper-contracture of  car-
diomyocytes, membrane disruption and subsequent band 
necrosis[16,17]. Clearly the recovery of  pH, oxidative stress 
and Ca2+ overload can induce the abrupt opening of  the 
mitochondrial permeability transition pores (mPTP), a 
large conductance pore in the inner mitochondrial mem-
brane (IMM), which strongly contributes to cardiomyo-
cyte hyper-contracture, apoptosis and necrosis[18-22].
MPTP
This pore is a high conductance megachannel, which 
builds up at the contact sites between the mitochondrial 
outer and inner membranes. When the mPTP is formed, 
it permits communication between the cytoplasm and 
mitochondrial matrix[23]. The molecular identity of  the 
protein(s) forming this pore is still unknown. It has 
been suggested that the mPTP is formed by the voltage-
dependent anion channel in the outer mitochondrial 
membrane (OMM), the adenine nucleotide transporter 
in the IMM, and cyclophilin D (Cyp D) in the matrix of  
mitochondria. mPTP opening seems to be facilitated by 
binding of  the matrix protein Cyp D to the IMM in a 
process regulated by both Ca2+ and inorganic phosphate 
(Pi)[19] (Figure 1). However, even experiments with trans-
genic mice in each of  the putative components of  mPTP 
reached controversial results[24-31]. 
mPTP opening: The oxidative opening of  mPTP is 
central in reperfusion injury (Figure 2A). Many studies 
have indeed revealed an important contribution of  mPTP 
opening and have correlated cell death with the release of  
cytochrome c (Cyt c) after Bax and enhanced ROS lev-
els[22,32-35].
Importantly, the opening probability of  mPTP of  the 
de-energized mitochondria is drastically reduced below pH 
7.4, a condition occurring during sufficiently prolonged 
ischemia[36]. Low pH also reduces mitochondrial calcium 
uptake and favors calcium extrusion from the mitochon-
drial matrix, due to the activation of  mitochondrial NHE 
and subsequent NCE[37]. However, low pH may activate 
uncoupling proteins (UCPs), IMM carriers of  H+ that un-
couple ATP synthesis from oxygen consumption[38]. For 
the role of  UCPs in cardioprotection see below[39-41]. Low 
pH may also inhibit glycolysis and pyruvate production, 
resulting in a slower feeding of  the respiratory complex 
chain. Therefore low pH mainly prevents mPTP opening 
in ischemia (Figure 1A).
On reperfusion, quite different conditions are created 
depending on whether or not the mitochondrial mem-
brane potential rapidly recovers. In the case of  energized 
respiring mitochondria, a low pH can stimulate Pi uptake 
increasing its intra-mitochondrial content, thus acting as 
an mPTP opener[42]. In contrast, in the presence of  mito-
chondrial membrane depolarization, long-lasting opening 
of  the mPTP take places when rapid normalization of  tis-
sue pH occurs in the presence of  Ca2+ overload, Pi, ROS 
formation, and/or lower levels of  NO•[32,43-46]. The latter 
condition (i.e. membrane depolarization and rapid pH nor-
malization) is the more common scenario upon abrupt re-
perfusion. In fact, the probability of  this pore being open 
is facilitated by several factors including high pH, Ca2+ 
overload, and burst of  ROS at the onset of  reperfusion. 
Apart from its direct action on mitochondria, the opening 
effect of  Ca2+ is also due to indirect effects, such as phos-
pholipase A2 and calpain activation[47-50] (Figure 1A).
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Consequences of  mPTP opening: Depending on the 
complex balance between cellular inducers and antago-
nists, mPTP can undergo transient or intermediate/long-
lasting opening[51]. mPTP opening of  short duration is 
likely to generate reversible cellular changes, so that this 
transient opening has been suggested to be involved in 
physiological processes and cardioprotection, such as 
intracellular NAD+ traffic, and transient formation of  
ROS (see also below)[52-55]. Actually, the transient increase 
in the opening probability of  mPTP is involved in ROS-
dependent triggering of  cardioprotection by precondi-
tioning[56,57] (see below).
While a transient/intermediate pore opening may or 
may not lead to apoptosis, long-lasting pore formation is 
followed by profound alterations of  cellular bioenerget-
ics that are considered irreversible; it results in increased 
mitochondrial permeability to ions and solutes with mo-
lecular weights of  up to 1.5 kDa, matrix swelling and loss 
of  critical electrochemical gradients. In this condition the 
F0F1ATPase actively hydrolyzes rather than synthesizes 
ATP, leading to inevitable cell death[11,12,33,58,59]. Actually, the 
mandatory consequence of  long-lasting mPTP opening is 
the collapse of  mitochondrial membrane potential. This 
is rapidly followed by ATP and NAD+ depletion, mito-
chondrial release of  accumulated Ca2+, matrix swelling and 
rupture of  the OMM leading to loss of  pyridine nucleo-
tides and release of  pro-apoptotic factors such as Cyt c, 
which triggers apoptosis and thus also inhibits electron 
flow through the electron transport chain[11,19,20,32,60-62]. Many 
have postulated that long-lasting mPTP formation is the 
event that leads to irreversible changes in cellular function 
and cell death[13,59,62,63]. Di Lisa et al[62] were among the first 
to observe that addition of  Ca2+ to mitochondria causes or-
ganelle swelling and profound decreases in NAD+ content.
At least two mechanisms which are not mutually exclu-
sive have been proposed to explain mitochondrial mem-
brane permeabilization and apoptosis. Apart the mPTP, 
which involves the participation of  both the IMM and 
the OMM, a mechanism of  mitochondrial death which 
involves only the OMM and the formation of  channels 
across the membrane has been described. Although there 
is controversy concerning the structure, the regulation and 
the definite role of  these two putative different channels, 
strong evidence indicates that proteins of  the Bcl-2 family 
may contribute to both mechanisms[64,65].
Prevention of  prolonged mPTP opening: All these 
opening factors are counteracted by “physiological” 
mPTP antagonists, such as adenine nucleotides (mainly 
ADP), elevated concentrations of  protons (i.e. pH be-
low 7.4), increased mitochondrial membrane potential, 
and magnesium ions, as well as by physiological levels of  
nitric oxide[19,66]. The pore is rapidly closed if  Ca2+ is che-
lated[19,60]. Promotion of  mPTP opening is also prevented 
by some drugs, including cyclosporine A (CsA), which at 
nM concentrations is a mPTP desensitizer[36,58,67]. Notably, 
in the absence of  Pi the desensitizing effects of  CsA are 
no longer present[58,67].
Since mPTP formation is likely to be a causative event 
in reperfusion injury and a major proportion of  cell death 
results from mPTP formation, it is not a surprise that 
cardioprotective strategies demonstrated that inhibition 
of  mPTP is the end-effector of  cardioprotection (Figures 
1B and 2). In fact the importance of  mPTP closure as 
a target for myocardial protection has been described in 
several studies[58,68-70]. The mechanisms of  cardioprotec-
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Figure 1  Flowchart depicting the variations of pH, ROS and mPTP open-
ing during ischaemia and reperfusion phases in the control hearts, and in 
hearts protected by preconditioning or postconditioning. A: In the control 
hearts reactive oxygen species (ROS) production slightly increases during the 
initial part of ischaemia until the O2 is exhausted. Then sharply increases in reper-
fusion. Formation of mitochondrial permeability transition pores (mPTP) had been 
limited during ischaemia by the low pH despite increased cellular levels of ROS, 
Ca2+ and Pi overload. But as pH returns to its baseline level and ROS formation 
increases prolonged opening occurs. The limited damages occurring during isch-
aemia are exacerbated by the prolonged mPTP opening which mediates irrevers-
ible cell damages in reperfusion. The opening effect, besides Ca2+ overload, is 
also due to indirect effects, such as  phospholipase A2 (PLA2) and calpain activa-
tions and consequent arachidonic acid release after membrane phospholipids 
degradation. A part membrane depolarisation also inorganic phosphate (Pi), lower 
levels of nitric oxide (NO) contribute to mPTP opening. Other factors which regu-
late pore formation are Bcl-2–associated X protein (Bax)/Bcl-2-associated death 
promoter (Bad), B-cell lymphoma 2 (Bcl-2) and glycogen synthase kinase 3 β 
(GSK-3β). Pore opening leads to cell-death through the release of pro-apoptotic 
factors as cytochrome c (Cyt c) and via ROS-induced ROS release (RIRR); B: 
The pre/postconditioned hearts are characterized by delayed pH recovery, ROS 
signalling and activation of protective pathways (e.g. Reperfusion Injury Salvage 
Kinases (RISK)/Survivor Activating Factor Enhancement (SAFE). These condi-
tions contribute to reduce mPTP opening and consequent cell death limitation. 
The details of the protective signalling (RISK/SAFE) can be seen in  Figure 2 and 
Figure 3. For further explanations see the text.
Perrelli MG et al �� Mitochondria and ROS in Cardioprotection
Ischaemia
Reperfusion
Cell death
[Ca2+]
[Pi]i
pH
ROS
↑
↑
↓
↑
mPTP opening (?)
Limited damages
[Ca2+]
[Pi]i
pH
ROS
(RIRR)
NO
↑
↑
↑
↑
↓
↑
↓
Prolonged mPTP opening
Irreversible damages
RIRR
Bax/Bad, GSK3β
activation
Cyt c release
Arachidonic acid
release
In reperfusion:
   �elayed pH 
   recovery
   RISK/SAFE 
   pathways 
   activation
   Low ROS 
   levels (ROS 
   signaling)
   No or brief 
   mPTP opening
Cell survival
Ischaemia Reperfusion
IP PostC
Protective manouvres
A B
tion and mPTP closure in reperfusion are described in 
the following section. 
CARDIOPROTECTIVE STRATEGIES 
TARGETING MITOCHONDRIA 
Lethal reperfusion injury appears to represent from 20 to 
70% of  the total amount of  irreversible myocardial dam-
age according to the studied species and therefore consti-
tutes a major therapeutic target[2,71-75].
Preconditioning and postconditioning
Over the last decades ischemic preconditioning and 
postconditioning have been recognized as protective phe-
nomena and have been confirmed in humans; they share 
certain signaling elements in experimental analyses[2,76-78] 
(Figure 2). In 1986, Murry et al[79] reported that four 5 min 
circumflex occlusions, each separated by 5 min of  reper-
fusion, followed by a sustained 40 min occlusion (index 
ischemia = infarcting ischemia) in the dog heart dramati-
cally attenuated ischemia/reperfusion injury. This phe-
nomenon was named ischemic Preconditioning (PreC). In 
2003, Zhao et al[73] reported that three episodes of  30 s of  
reperfusion/30 s of  ischemia performed immediately af-
ter index ischemia (60 min coronary occlusion) in the dog 
heart drastically attenuated reperfusion injury. This phe-
nomenon was named ischemic Postconditioning (PostC). 
It was soon clear that the later the application of  the first 
postconditioning ischemia, the lower the protection. 
The recognition of  the ischemic PostC phenomenon 
put an end to any discussion on the existence of  reperfu-
sion injury[80]. The term “PostC” has also highlighted the 
importance of  intervening at the beginning of  myocardial 
reperfusion to protect the post-ischemic heart; a clinically 
more relevant time-point for intervention in patients pre-
senting with an AMI. As such, its clinical application has 
been rapid for both ST-elevation AMI patients undergo-
ing primary percutaneous coronary intervention (PCI)[81,82] 
and for patients undergoing on-pump cardiac surgery[83] 
(see also below).
The protective effects observed with PostC are com-
parable to those observed with the powerful PreC[2,73,84,85]. 
In fact, PostC may reduce apoptosis, necrosis, and endo-
thelial dysfunction/activation, thus leading to a reduced 
endothelium/leukocyte interaction and to reduced ROS 
inflammatory formation[5,73]. PostC also reduces the inci-
dence of  reperfusion arrhythmias[86-90].
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Figure 2  Flowchart depicting the main factors involved in cardioprotective pathways triggered by pre and postconditioning. Activation of cell-surface recep-
tors in response to an ischaemic conditioning stimulus recruits cGMP/PKG, RISK and SAFE pathways. In particular, iNOS seems to be involved in SAFE pathway[77]. 
These signal transduction pathways, together with acidosis, activated at the time of reperfusion will crosstalk and will terminate on mitochondria to activate protective 
pathways. Akt: Serine/threonine protein kinase; cGMP/PKG: Cyclic guanosin monophosphate/protein kinase G;  eNOS: Endothelial NO synthase; ERK1/2: Extracel-
lular regulated kinase 1/2; gp130: Glycoprotein 130; GPCR: G-protein-coupled receptor; GSK3β: Glycogen synthase kinase 3 β; IL-6: Interleukin 6; iNOS: Inducible 
NO synthase; JAK: Janus kinase; MEK: Mitogen-activated protein kinase kinase; mPTP: Mitochondrial permeability transition pore; NO: Nitric oxide; P70S6K: p70 
ribosomal S6 protein kinase; PI3K: Phosphoinositide 3-kinase; PKG: Protein kinase G; RISK: Reperfusion injury salvage kinases; SAFE: Survivor activating factor 
enhancement;  STAT-3: Signal transducer and activator of transcription 3; TNFα: Tumour necrosis factor α; TNF-R2: Tumour necrosis factor receptor 2.
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Intensive investigation of  the signaling pathways un-
derlying PreC and PostC have identified a number of  sig-
nal transduction pathways conveying the cardioprotective 
signal from the sarcolemma to the mitochondria, some 
of  which overlap for PreC and PostC. In fact, both PreC 
and PostC induce activation of  signaling elements dur-
ing the early reperfusion following the index ischemia[91] 
(Figure 2). Great attention has focused on the cyclic 
guanosine monophosphate (cGMP)/protein kinase G 
(PKG)-pathway[92-94], on the Reperfusion Injury Salvage 
Kinases (RISK) pathway[95,96], which involves the kinases 
Akt and ERK1/2, and more recently on the Survivor 
Activating Factor Enhancement (SAFE) pathway that has 
been suggested to contribute to PostC protection through 
the activation of  tumor necrosis factor (TNF)-α, its re-
ceptor type 2, Janus kinase (JAK) and signal transducer 
and activator of  transcription (STAT)-3[78,97]. All these 
pathways in preconditioning and postconditioning con-
verge on the mitochondria via the modulation of  several 
kinases including glycogen synthase kinase-3β, Bax/Bad 
and the ε isoform of  protein kinase C (PKC) (for reviews 
see[10,78]). The modalities of  mitochondrial control by cy-
tosolic kinases depicted in Figures 2 and 3 are still contro-
versial and are beyond the aims of  this editorial.
Nevertheless, ROS signaling and acidosis in early reper-
fusion are two cardioprotective processes operating in early 
reperfusion in both preconditioning and postconditioning 
(Figures 2 and 3). They may act, first, directly on mPTP 
components to limit their opening and, then, may activate 
signaling pathways that have been suggested to converge 
again on mitochondria to decrease the susceptibility to 
mPTP opening and mediate protection (Figures 2 and 3). 
These two processes are discussed in the next sections.
ROS signaling and acidosis in early reperfusion
Before considering the beneficial role or ROS signaling, 
let us consider the forms and the detrimental effects of  
ROS within the heart. 
Forms of  ROS: ROS are generated in different cellular 
compartments and by several enzymes, including NADPH 
oxidases at the plasma membrane[98,99] and cytosolic xan-
thine oxidases[100]. Although ROS are produced by several 
extracellular and intracellular processes, in cardiomyocytes 
the mitochondria represent the most relevant site for 
ROS formation[101-105]. Within the mitochondria, most of  
the oxygen is reduced to water at respiratory complex IV. 
The mitochondrial formation of  ROS might be modu-
lated by NO•[106-108] which reversibly inhibits cytochrome 
oxidase[105,109-112]. This inhibition can be transformed into 
irreversible alterations of  the respiratory chain when 
NO• reacts with O2-• to generate a large amount of  per-
oxynitrite, which can produce the irreversible nitration 
of  proteins[113]. Even nitric oxide synthases can become 
“uncoupled” resulting in the generation of  O2-• and OH•, 
instead of  NO• under certain conditions, such as scar-
city of  substrate and/or cofactors[112,113]. Apart from the 
electron transport chain, ROS can also be produced by 
monoamine oxidases (MAOs) in the OMM. MAOs trans-
fer electrons from amine compounds to oxygen to gener-
ate hydrogen peroxide[102,114,115]. Within the mitochondria, 
p66Shc oxidizes reduced Cyt c, which induces the partial 
reduction of  oxygen to peroxide[116-118].
Besides being a relevant site for ROS formation, mito-
chondrial function and structure are profoundly altered by 
oxidative stress[34], especially when mPTPs have long-last-
ing opening. In fact, mPTPs play a central role in the so-
called ROS-induced ROS release (RIRR)[61,119,120]; excessive 
ROS facilitate mPTP opening which in turn favors ROS 
formation by inhibiting the respiratory chain because of  
mPTP-induced loss of  Cyt c and pyridine nucleotides[12,34]. 
This vicious cycle is likely to be established at the onset of  
a rapid reperfusion when a large increase in ROS forma-
tion occurs along with pH recovery, and Ca2+ overload, 
thus inducing injury amplification, as discussed above and 
below (Figure 1).
Detrimental effects of  excessive ROS: Various detri-
mental processes can result from an imbalance between 
the excess formation of  ROS and limited antioxidant 
defenses (referred to as ‘oxidative stress’). For instance, 
excessive ROS indiscriminately react with DNA, lipids and 
proteins[113,120-123]. The lack of  protection of  mitochondrial 
DNA by histones, the limited capacity of  repair mecha-
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Figure 3  Extra- and intra-mitochondrial signalling: interactions among 
Cx43, mKATP, PKCε, ROS, and mPTP. The mPTP is believed to be composed 
of the adenine nucleotide transporter (ANT) in the inner membrane (IMM), 
the voltage-dependent anion channel (VDAC) of the outer membrane (OMM), 
and cyclophilin D (Cyp D) in the matrix. Signals arising from RISK and SAFE 
pathways are delivered to mitochondrial permeability transition pore (mPTP) via 
nitric oxide (NO)/glycogen synthase kinase 3 β (GSK3β) and signal transducer 
and activator of transcription 3 (STAT-3), respectively, and then to connexin 43 
(Cx43) on the IMM. Signals arising from cGMP/PKG are delivered to mitochon-
dria via the terminal protein kinase G (PKG). PKG phosphorylates an unknown 
OMM receptor, “R1”, whereas PKCε act in conjunction to activate a distinct 
OMM receptor, “R2”. These OMM receptors transmit the signal by an unknown 
mechanism to PKCε1 located at the IMM. The activated PKCε1 phosphorylates 
and opens mitochondrial ATP-sensitive potassium (mKATP). Also Cx43 located 
at the IMM regulated mKATP opening. The mKATP opening via PKCε1 causes 
K+ uptake and increased ROS production from respiratory chain. ROS pro-
duced by mKATP activation now diffuses and activates both PKCε1 and PKCε2 
on the IMM and PKCε in the cytosol. ROS signalling may represent the link 
between mitochondria and cytosol. mPTP opening is prevented by cytosolic pH 
lowering, ROS signalling and PKCε2 activation.
nisms and the proximity of  mitochondrial DNA to the 
production site of  ROS by RIRR render the mitochondrial 
DNA highly susceptible to increased oxidative stress[124]. 
Excessive oxidative stress, besides contributing to irrevers-
ible myocardial injury, induces long-lasting mPTP opening 
leading to cellular dysfunction and cell death, and may 
also induce reversible injury during ischemia and reperfu-
sion[105,125-128]. The reversible contractile dysfunction follow-
ing myocardial ischemia/reperfusion (“stunning”) is clearly 
a manifestation of  excessive oxidative stress[129,130]. Whether 
stunning is due to RIRR has not yet been investigated.
On the other hand, as mentioned above, low levels of  
reactive species may act as secondary messengers, modu-
lating cardioprotective signaling pathways by covalent 
modification of  target molecules, referred to as ‘redox 
signaling’ or “ROS signaling”, which is the main topic of  
the next section.
Beneficial effects of ROS signaling and acidosis - focus 
on early reperfusion 
It has been proposed that reintroduction of  oxygen after 
transient ischemia induces ROS production, but it does 
not protect against reperfusion injury because mPTPs 
open and trigger RIRR before the activation of  endog-
enous survival pathways.
The key event for cardioprotection may be prolonga-
tion of  cellular acidosis by cardioprotective phenomena 
during early reperfusion (Figure 2B). In fact acidic perfu-
sion in early reperfusion or PostC, delaying pH normal-
ization, could inhibit mPTP during the first minutes of  
reflow and allow for endogenous protective signaling 
pathways to be activated by ROS signaling. The delivery 
of  oxygen during acidic perfusion or the brief  intermit-
tent reperfusions of  PostC would promote mitochondrial 
ROS formation which has been proposed to activate 
isoforms of  PKC through redox signaling[131]. Different 
isoforms of  PKC appear as critical kinases in the signaling 
cascade leading to a reduced probability of  mPTP open-
ing after pH normalization[131-134] (see Figure 3 and below).
Not only mPTPs may be inhibited by a limited ROS 
production and acidosis, but also, as mentioned above, 
a transient or short duration opening of  the mPTP 
has been suggested to induce a slight, transient forma-
tion of  ROS that might be relevant for cardioprotec-
tion[51-54,56,57,135]. Supporting this concept, pharmacological 
and genetic inhibition of  Cyp D was reported to attenu-
ate both preconditioning-induced ROS formation and 
protection[136,137]. In brief, in protected reperfusion, low 
levels of  ROS may act directly on mPTP components 
or activate signaling pathways that have been suggested 
to act on mitochondria decreasing their susceptibility to 
prolonged mPTP opening.
Redox signaling by transient/reduced formation of  
ROS is also included among the triggers of  PostC[138]. In 
fact, we were the first to show that the ROS scavengers 
N-acetylcysteine (NAC)[132] and N-2-mercaptopropionyl 
glycine (MPG) prevent the protective effects of  ischemic 
or pharmacological PostC[94,132,139,140], and the same ROS 
scavenger has been shown to block the protection af-
forded by acidic reperfusion[141]. In our laboratory isolated 
rat hearts were subjected to ischemia and reperfusion. 
While PostC significantly reduced infarct size, protection 
by PostC was lost in hearts perfused with NAC for the 
entire reperfusion period. Infarct size was still reduced 
when, in postconditioned hearts, perfusion with NAC was 
initiated after the first 3 min of  reperfusion, demonstrat-
ing an essential role of  ROS formation during early reper-
fusion in PostC protection[132]. Cardioprotection, induced 
with acidic buffer for the first 2 min of  reperfusion, was 
blocked by MPG applied for 20 min in reperfusion[141], 
suggesting the involvement of  ROS signaling in acidosis-
induced protection. Infarct size reduction by either isch-
emic PostC, 1.4% isoflurane or 10 mg/kg of  delta-opioid 
receptor agonist SNC-121 in mouse hearts in vivo were at-
tenuated by the ROS scavenger MPG when administered 
a few minutes before but not 10 min after the postcondi-
tioning stimulus[140]. NAC in the first minutes of  reperfu-
sion also abolished postconditioning by bradykinin or 
sevoflurane in isolated rat hearts[94,139]. Importantly, in the 
human myocardium, desflurane-induced postconditioning 
was mediated by adenosine and bradykinin receptors via 
ROS signaling[115]. These studies support a central role for 
ROS signaling during early reperfusion in the protection 
by ischemic postconditioning and in the protection by aci-
dosis in early reperfusion.
Mitochondrial ATP-sensitive potassium channels
Mitochondrial ATP-sensitive potassium (mKATP) chan-
nels in the mitochondrial inner membrane are considered 
targets of  protective cascades, and play a pivotal role in 
ROS production, mainly superoxide anion derived from 
complex I of  the electron transport chain[21,76,138,142,143]. 
Opening of  the mKATP channels and subsequent gen-
eration of  ROS is considered to be a pivotal step in the 
mechanisms of  pre- and postconditioning[3,21,76]. We 
found evidence that ROS signaling is downstream of  
mKATP channel opening in isolated rat hearts subjected 
to ischemia/reperfusion with an intermittent infusion 
of  diazoxide or diazoxide plus MPG at the onset of  
reperfusion, since MPG attenuated diazoxide-induced 
protection. However, while ROS scavenging attenuates 
infarct size reduction by postconditioning or diazoxide, 
increasing exogenous ROS formation with purine/xan-
thine oxidase at the onset of  reperfusion does not confer 
protection[94]. It is likely that the type, the concentration, 
and/or the compartmentalization of  reactive species may 
play a pivotal role in triggering protection at reperfusion. 
Nevertheless, we cannot rule out that a different ROS 
generator could trigger PostC protection.
In the context of  cardioprotection, it has been re-
ported that PKG- and/or Akt-dependent phosphoryla-
tion induces the opening of  mKATP promoting K+ entry 
into mitochondria with consequent alkalinization of  
the mitochondrial matrix and generation of  ROS with a 
protective signaling role. Indeed, PKG phosphorylates a 
protein on the OMM, which then causes the mKATP on 
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the IMM to open. This implies that the protective signal 
is transmitted from the OMM to the IMM. This is ac-
complished by a series of  intermembrane signaling steps 
that includes PKCε activation. The resulting ROS then 
activate a second PKC pool which, through another sig-
nal transduction pathway causes inhibition of  the mPTP 
(the end effector) and reduction in cell death[3,76,144-146] 
(Figure 3). Pharmacological opening of  mKATP chan-
nels by diazoxide contributes to the formation of  small 
amounts of  ROS[147]. Also, NO• donors can activate 
mKATP channels in rabbit ventricular myocytes and can 
potentiate the protective effect of  the mKATP opener di-
azoxide[143]. Besides cGMP/PKG-dependent phosphory-
lation, mKATP could be opened by direct reaction of  NO• 
and derivatives (S-nitrosylation), as well as by the action 
of  H2S via S-sulfhydration[4]. However, controversy exists 
on the nature, existence and opening of  mKATP channels, 
which may also be a toxic process[145,148]. PKC activation 
leading to the opening of  mKATP channels has been chal-
lenged by the Halestrap group: they demonstrated that 
preconditioning inhibits opening of  the mPTP in situ, 
by an indirect mechanism probably involving decreased 
ROS production and Ca2+ overload at reperfusion[11,148].
Mitochondrial uncoupling
Mitochondrial uncoupling, i.e. proton influx into the 
mitochondrial matrix without phosphorylation of  ADP, 
contributes to ROS formation[39,40]. Although controversy 
exists on the cardioprotective role of  uncoupling, mild 
uncoupling secondary to activation of  UCPs has been 
described to confer cardioprotection under several condi-
tions, including myocardial reperfusion, likely by decreas-
ing ROS production[41]. Intriguingly, it has been suggested 
that transient complex I inhibition during reperfusion 
is cardioprotective via attenuated ROS production[149,150]. 
Nevertheless, experimental evidence supporting the in-
volvement of  these changes in PostC protection has yet 
to be provided. Whether UCPs play a deleterious or pro-
tective role in ischemia tolerance is controversial[39-41].
Mitochondrial connexin-43
Mitochondrial connexin-43 (Cx43) has also been impli-
cated in ROS-signaling, though its role is not completely 
defined[21,151,152]. Actually, within cardiomyocytes Cx43 is 
mainly localized at gap junctions, but it is also present 
in other organelle membranes, including the IMM of  
sarcolemmal mitochondria[152-154] where Cx43 regulates 
mitochondrial potassium flux[155,156]. It seems that Cx43 
transolocates to the IMM, with cardioprotection via the 
intervention of  heat shock protein 90-TOM (transloca-
tion of  the outer membrane) import pathway[154].
Mitochondrial Cx43 has been described to be essen-
tial for preconditioning protection[154,157,158], but a recent 
study in mice heterozygous for Cx43 (Cx43+/-) indicates 
that it does not play a significant role in PostC protec-
tion. Actually, Cx43 is a target of  several protein kinases, 
and mitochondrial Cx43 is highly phosphorylated under 
physiological conditions[159]; it seems that in the IMM of  
a subset of  cardiomyocyte mitochondria, subsarcolem-
mal mitochondria, the phosphorylated portion of  Cx43 
increases with ischemia[152] and decreases with PostC[138]. 
Since a decrease in the mitochondrial Cx43 content is 
sufficient to abolish the cardioprotection by diazoxide 
preconditioning, i.e. reduces ROS formation[147], one can 
speculate that Cx43 reduction in PostC may be one of  
the mechanisms to reduce excessive ROS production in 
the reperfusion phase. Recently it has been suggested 
that genetic ablation or pharmacological inhibition of  
mitochondrial Cx43 confers resistance to mKATP channel 
opening in response to diazoxide in patch-clamped mito-
plasts (mitochondria devoid of  the OMM). However, the 
open-probability of  the mKATP channel was not affected 
under baseline conditions; thus it is likely that Cx43 
regulates this channel activity rather than constituting the 
pore forming unit of  the mKATP channel[156].
Timing and targets of ROS signaling in cardioprotection
In the context of  cardioprotection, reactive species with 
a signaling role are suggested to be formed during three 
time points: (1) during preconditioning-ischemia and/or 
(2) during reperfusion that follows the brief  precondi-
tioning-ischemia; and (3) in the initial part of  reperfusion 
that follows the index ischemia; both in the postcondi-
tioning and in the preconditioning context.
During preconditioning-ischemia: A wide body of  evi-
dence exists demonstrating that appreciable formation of  
ROS occurs during ischemia[126,128,160-162]. In fact, mitochon-
drial ROS formation is favored by a decrease in electron 
flow resulting from respiratory chain inhibition, and is 
counteracted by uncoupling that is generally produced by 
an increased IMM permeability to protons. Therefore, the 
inhibition of  the electron transport chain caused by insuf-
ficient oxygenation facilitates the escape of  electrons that 
can react directly with the scarce available oxygen resulting 
in ROS formation.
During reperfusion that follows brief  precondition-
ing-ischemia: Small amounts of  ROS may be formed 
during reperfusion following a short period of  precon-
ditioning ischemia. To support this viewpoint, the group 
of  Downey[163] used MPG (a cell-permeant ROS scav-
enger[164]) to test whether the ROS that triggers protec-
tion are produced during the ischemic or the reperfusion 
phases of  the preconditioning maneuvers. These authors 
concluded that protective redox signaling occurs when 
molecular O2 is reintroduced following the brief  precon-
ditioning coronary occlusion. 
In the initial part of  reperfusion that follows the in-
dex ischemia in postconditioning: The above observa-
tions were done in the preconditioning phase, i.e. before 
the index ischemia, and extended to PostC itself. In fact, 
as reported above, the protective effect of  PostC was at-
tenuated by infusing, during early reperfusion, large spec-
trum ROS scavengers, making the oxygenated perfusate 
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alkaline during the early reperfusion phases or making the 
early reperfusion buffer hypoxic[50,94,131,132,142,165].
Early reperfusion events in preconditioned heart: 
Clearly, both PreC and PostC, besides sharing a number 
of  signaling elements, induce activation of  signaling ele-
ments (RISK and SAFE) during early reperfusion fol-
lowing the prolonged index ischemia[78,91,166] (Figure 2). It 
is now thought that, after a triggering phase in the pre-
ischemic period, the actual protection by PreC occurs in 
the reperfusion rather than in the ischemic phase, with 
the repopulation of  sensitized G-protein-coupled recep-
tors at the beginning of  myocardial reperfusion following 
the index ischemia[167]. Hence, reintroduction of  O2 at the 
beginning of  reperfusion permits generation of  signaling 
ROS, which will activate the PKC-dependent signaling 
cascade. In fact the PreC protective effect was also at-
tenuated by infusing. during early reperfusion. large spec-
trum ROS scavengers, making the oxygenated perfusate 
alkaline during the early reperfusion phase or making the 
early reperfusion buffer hypoxic[56,166,167].
Targets of  ROS signaling: Reactive species function 
as trigger molecules of  protection by activating protein 
kinases such as PKC within and outside the mitochon-
dria[3,146,147,168,169], as well as the mitogen-activated protein 
kinase p38 and/or JAK/STAT[170,171]. Several mitochondrial 
components are targeted by reactive species via oxidative/
nitrosative processes[4,10]. Accordingly, many large spectrum 
scavengers of  ROS, such as ascorbic acid, MPG or NAC, 
attenuate infarct size reduction by ischemic or pharmaco-
logical PreC or PostC, in several animal species[2-4,132,145,169,172]. 
Since a target of  ROS in redox signaling is the PKC, hearts 
can be preconditioned by simply infusing free radicals into 
the coronary arteries, and that protection can be blocked by 
a PKC antagonist[76,167]. Evidence exists that ROS-activated 
PKC will also protect the reperfused heart[132,169]. This se-
quence would explain the observation that a PKC activator 
could rescue hearts experiencing acidic and hypoxic reper-
fusion[131]. Moreover, chelerythrine, a non-specific PKC 
antagonist, blocks PostC protection[132-134]. 
Indeed, it has been reported that ROS can activate 
PKC in vitro by reacting with thiol groups associated with 
the zinc finger region of  the molecule[173]. Reactive nitro-
gen species-dependent activation of  PKC, possibly via 
a redox-sensitive S-nitrosylation process, has been also 
suggested; a process which also occurs within mitochon-
dria[4,174,175]. Recently, we have observed in an ex vivo study 
that PostC induces downregulation of  superoxide dis-
mutase (SOD), whereas catalase activity does not change 
in the early reperfusion phase. Moreover, PostC reduces 
3-nitrotyrosine and increases S-nitrosylated protein levels, 
thus contributing to cardioprotection triggering[176]. The 
persistence of  acidosis[50,68,131,141,165] and the NO• augmenta-
tion (enzymatic and non-enzymatic production)[132] in early 
reperfusion of  postconditioned hearts, together with SOD 
downregulation may favor nitrosylation and/or may limit 
protein de-nitrosylation. In fact SOD is a de-nitrosylating 
enzyme[177]. Intriguingly, exogenous-SOD prevents PostC-
triggering, whereas exogenous-catalase does not interfere 
with PostC protection. That is, the addition of  exogenous-
SOD during PostC maneuvers does not allow the early re-
duction in overall SOD activity, usually induced by PostC.
Preservation of functional and morphological integrity 
of mitochondria
Preconditioning and postconditioning activate cardiopro-
tective pathways that are protective against reperfusion 
injury via preservation of  the functional and morpho-
logical integrity of  mitochondria. The protection of  
PostC against apoptosis is mediated by reduced genera-
tion of  superoxide anions, lowered activity of  c-Jun-N-
terminal kinases/p38, lowered levels of  caspases 3 and 
8, reduced release of  TNFα, and by the modulation of  
the Bax/Bcl-2 ratio[178]. PostC increases the levels of  anti-
apoptotic markers, including the cardioprotective kinase 
Pim-1, decreases pro-apoptotic markers, e.g. Cyt c, and 
preserves the mitochondrial structure. In fact, at the onset 
of  reperfusion, mitochondria undergo profound struc-
tural alterations. In particular, post-ischemic mitochondria 
are characterized by disruption of  membranes, broken 
christae and the appearance of  dense granules within the 
mitochondrial matrix, which are caused by massive accu-
mulation of  Ca2+, generating insoluble calcium phosphate 
precipitate[179]. These mitochondrial damages are reduced 
by PostC[138]. Carbonylation of  mitochondrial proteins 
was prevented and aconitase activity was preserved in 
the PostC hearts suggesting that mitochondrial integrity 
was associated with a diminution in oxidative stress[180]. 
However, PostC does not influence mitochondrial respira-
tion[181]. In particular, PostC does not affect basal state 4 or 
ADP-stimulated state 3 respiration, excluding uncoupling 
or inhibition of  the respiratory chain as a mechanism of  
mPTP inhibition[182]. Nevertheless, while basal respira-
tion was not affected, ADP-stimulated respiration was 
increased after pharmacological PostC with morphine[183]. 
This is in line with many reports showing that a mild 
degree of  mitochondrial dysfunction confers protection 
against ischemia/reperfusion injury[175,184].
In summary, ROS signaling before index ischemia, i.e. 
during brief  preconditioning ischemia and/or during the 
following reperfusion, is clearly involved in the triggering 
of  preconditioning protection. Excessive ROS formation 
during reperfusion, following infarcting ischemia, enhances 
cell death, but ROS signaling during early reperfusion is 
essential for protection of  ischemic and some pharma-
cological preconditioning and postconditioning against 
reperfusion injury. In early reperfusion, opening of  mKATP 
channels may be upstream of  ROS signaling. Cardioprotec-
tive procedures delay the post-ischemic recovery of  intra-
cellular pH that may prevent mPTP opening directly and 
indirectly (i.e. by inhibiting calpain activation). In addition, 
mPTP opening may be further prevented by a ROS signal-
ing that appears to depend on acidosis and by a decrease in 
intracellular Ca2+. ROS signaling triggers a protective kinase 
cascade starting from PKC and converging on mPTPs. 
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Thus, mPTP closure may be dependent on ROS signaling 
effects, both upstream, together with an acidotic effect, and 
downstream, dependent on kinase effects. Therefore, mito-
chondria are involved in at least four different steps to limit 
reperfusion injury: (1) as the target of  acidosis (i.e. preven-
tion of  mPTP opening); (2) as triggers or signal amplifiers 
(i.e. activation of  mKATP channels and resulting formation 
of  small amounts of  ROS); (3) as the target of  signaling 
pathways and end-effectors (i.e. inhibition of  mPTP open-
ing and of  release of  pro-apoptotic factors into the cyto-
sol); and (4) as targets of  damage and protection from it (i.e. 
functional and morphological integrity).
THERAPEUTIC IMPLICATIONS
The signaling role of  ROS in early reperfusion must be 
kept in mind for successful treatment in reperfusion. 
Clearly, the mPTP is a major factor in determining cell 
death, and mPTP inhibition affords significant cardio-
protection[12,32,185,186], a concept that has been successfully 
translated into the clinical setting[81,82,187,188]. In particular, 
postconditioning transition to the clinical setting has prov-
en the existence of  lethal myocardial reperfusion injury in 
man, and the clinical studies suggest that 40%-50% of  the 
final reperfused infarct in humans may be attributable to 
myocardial reperfusion injury[189]. 
In AMI patients the involved coronary artery may 
be opened by either angioplasty or thrombolysis, with or 
without application of  a stent. The ischemic postcondi-
tioning, though reserved for patients reperfused by pri-
mary angioplasty, may provide impressive results when the 
no-reflow phenomenon, the infarct size and the myocardi-
al contractile function are considered, raising great hopes 
for potential clinical benefits. Feasible in every patient, the 
pharmacological postconditioning, including CsA infu-
sion, would allow the expansion of  postconditioning pro-
tection to almost all ST-elevation AMI patients. Obviously 
restoring reperfusion to the ischemic myocardium is the 
definitive strategy in reducing infarct size. However, blood 
flow may not be restored to all segments of  the microvas-
culature in the post-ischemic myocardium[190], a situation 
that is associated with the no-reflow phenomenon as a 
predictor of  adverse long-term outcomes in patients[191]. 
The obvious implication of  low- or no-reflow is that the 
blood supply is inadequate to sustain contractile function, 
and the decrease may be severe enough to induce cell 
death of  the involved myocardium. Reducing the no-re-
flow area may lead to smaller infarcts, less adverse remod-
eling and less severe heart failure. Post-ischemic blood 
flow in a small group of  patients undergoing PCI for 
AMI was studied by Laskey[192]. Patients were assigned to 
receive standard care vs an “ischemic conditioning” stimu-
lus. While the control group (standard care) had a 90-s 
balloon inflation only before withdrawal of  the catheter, 
the conditioned group had a 90-s inflation followed by 3-5 
min of  balloon deflation, and after that the balloon was 
advanced distal to the stenosis. These conditioned patients 
have shown an improved post-ischemic coronary blood 
flow as revealed by an increased peak coronary blood flow 
velocity, diastolic/systolic velocity ratio and blood flow 
velocity reserve (evaluated with Doppler flow wire) com-
pared to the control group. Staat et al[81] used blush grade, 
the speed by which contrast is washed out of  the myocar-
dium at risk, as a marker of  myocardial reperfusion after 
the initial period of  reflow in patients subjected to stan-
dard angioplasty or postconditioning, which consisted of  
four cycles of  60-s deflation/inflation of  the angioplasty 
balloon in the target vessel. In postconditioned patients 
the blush grade was 25% greater than that of  control pa-
tients. Also Ma et al[193] found that post-ischemic coronary 
blood flow in the target vessel was greater in AMI patients 
who received postconditioning treatment. This was associ-
ated with lower markers of  lipid peroxidation by ROS and 
lower plasma levels of  myocardial creatine kinase. More-
over, brachial arterial endothelium-mediated (flow-depen-
dent) relaxation in response to transient cuff  occlusion 
applied 24 h after PCI was better in the postconditioned 
patients. Although flow-dependent vasodilator effects in 
the brachial artery do not directly reflect physiology of  
the coronary vascular endothelium, it may be reflective 
of  a “remote” protection to the endothelium of  other 
organs, which then becomes a surrogate measure of  the 
coronary vascular endothelium. Actually remote ischemic 
postconditioning (conditioning stimuli applied to a distant 
organ during reperfusion of  the target organ) induced by 
transient episodes of  ischemia of  distant organs, including 
kidney, arms and legs, is a clinically feasible method for 
protecting the heart against injury at the time of  reperfu-
sion. Recently, it has been observed in rats that remote 
ischemic perconditioning may reduce infarct size, and that 
repeated remote postconditioning further reduces adverse 
remodeling of  the left ventricle and may improve survival 
in a dose-dependent fashion[194]. Indeed, remote postcon-
ditioning has been reported experimentally[194,195], and cor-
related with endothelial protection in humans[196,197]. Thus, 
although these data suggest that local and remote isch-
emic postconditioning have favorable effects on recovery 
of  microvascular perfusion following relief  of  ischemia, 
further experimental and clinical studies are needed to es-
tablish whether postconditioning attenuates microvascular 
injury and the extent of  no-reflow.
As mentioned above, a pharmacological approach may 
be more suitable. In fact, initial progress has been made 
with novel approaches for preventing myocardial reperfu-
sion injury by administering drugs in the first minutes of  
reperfusion; preliminary clinical data indicate that drugs 
targeting mPTPs or RISK may confer benefits to patients 
with AMI, with and without comorbidities, above that 
provided by myocardial reperfusion alone. Very good 
results are obtained with drugs such as CsA as an mPTP 
desensitizer[81,187,188], as well as with other drugs targeting 
RISK, such as erythropoietin and its analogs[198,199]. Impor-
tantly, similar cardioprotective effects were obtained with 
other drugs acting on mPTP, confirming the relevance 
of  this approach. For instance, derivatives of  CsA, such 
as [N-methyl-ala6]CsA, [N-methyl-Val4]CsA, Debio 025, 
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NIM811, or sanglifehrin A[11,12,56,58,59,68,71,136,189] also pre-
vented myocardial ischemia/reperfusion injury in an ex-
perimental setting. Importantly, in small, proof-of-concept 
trials[81,82,187,189], the administration of  CsA in patients with 
AMI at the time of  reperfusion has been associated with 
smaller infarct size. The efficacy of  treatment has been 
assessed measuring the release of  the cardiac biomarkers 
creatine kinase and troponin Ⅰ and by measuring the area 
of  late hyperenhancement of  the reperfused myocardium 
on magnetic resonance imaging (MRI). In one of  this 
studies[187], the area under the curve for the creatine kinase 
concentration suggested that the administration of  cy-
closporine induced a reduction in infarct size of  approxi-
mately 40%. This result was confirmed by a reduction in 
the area of  late hyperenhancement on MRI. However, the 
area under the curve for the troponin Ⅰ concentration was 
not significantly reduced by the administration of  cyclo-
sporine. Mewton et al[188] recently examined whether CsA 
modified left ventricle remodeling in patients. Cardiac 
MRI was performed at day 5 and after 6 mo. The authors 
reported that CsA did not exert any deleterious effect on 
left ventricle remodeling, and confirmed that infarct size 
reduction persisted after 6 mo. In addition, infarct size re-
duction by CsA was associated with a lower left ventricle 
dilatation at day 5, which was maintained at 6 mo. These 
data require confirmation in larger clinical trials. 
CONCLUSION
It appears that many different signals can induce (and 
inhibit) mPTP formation, strictly linking ischemia/reper-
fusion stress and damage to the mitochondria. This high-
lights the capacity of  mitochondria to function as general 
cell death sensors and to integrate many lethal signals. 
Clearly, mitochondria and ROS are attractive mechanistic 
targets for cardioprotection. Indeed, proof-of-concept 
studies demonstrated beneficial effects of  the mPTP de-
sensitizer CsA during early reperfusion in patients with 
AMI. Patient-tailored treatment to either prevent mPTP 
formation or the upstream events leading to mPTP open-
ing may be achievable in the next future.
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